Vis enkel innførsel

dc.contributor.authorHalle, Martin
dc.contributor.authorPrescott, Eva Bossano
dc.contributor.authorCraenenbroeck, Emeline M Van
dc.contributor.authorBeckers, Paul
dc.contributor.authorVidem, Vibeke
dc.contributor.authorKarlsen, Trine
dc.contributor.authorFeiereisen, Patrick
dc.contributor.authorWinzer, Ephraim B.
dc.contributor.authorMangner, Norman
dc.contributor.authorSnoer, Martin
dc.contributor.authorChristle, Jeffrey W.
dc.contributor.authorDalen, Håvard
dc.contributor.authorStøylen, Asbjørn
dc.contributor.authorEsefeld, Katrin
dc.contributor.authorHeitkamp, Melanie
dc.contributor.authorSpanier, Bianca
dc.contributor.authorAxel, Linke
dc.contributor.authorEllingsen, Øyvind
dc.contributor.authorDelagardelle, Charles
dc.date.accessioned2023-01-31T11:46:38Z
dc.date.available2023-01-31T11:46:38Z
dc.date.created2022-10-17T15:07:41Z
dc.date.issued2022
dc.identifier.citationAmerican Heart Journal Plus: Cardiology Research and Practice (AHJ Plus). 2022, 22 .en_US
dc.identifier.urihttps://hdl.handle.net/11250/3047388
dc.description.abstractBackground Exercise for heart failure (HF) with reduced ejection fraction (HFrEF) is recommended by guidelines, but exercise mode and intensities are not differentiated between HF etiologies. We, therefore, investigated the effect of moderate or high intensity exercise on left ventricular end-diastolic diameter (LVEDD), left ventricular ejection fraction (LVEF) and maximal exercise capacity (peak VO2) in patients with ischemic cardiomyopathy (ICM) and non-ischemic cardiomyopathy (NICM). Methods The Study of Myocardial Recovery after Exercise Training in Heart Failure (SMARTEX-HF) consecutively enrolled 231 patients with HFrEF (LVEF ≤ 35 %, NYHA II-III) in a 12-weeks supervised exercise program. Patients were stratified for HFrEF etiology (ICM versus NICM) and randomly assigned (1:1:1) to supervised exercise thrice weekly: a) moderate continuous training (MCT) at 60–70 % of peak heart rate (HR), b) high intensity interval training (HIIIT) at 90–95 % peak HR, or c) recommendation of regular exercise (RRE) according to guidelines. LVEDD, LVEF and peak VO2 were assessed at baseline, after 12 and 52 weeks. Results 215 patients completed the intervention. ICM (59 %; n = 126) compared to NICM patients (41 %; n = 89) had significantly lower peak VO2 values at baseline and after 12 weeks (difference in peak VO2 2.2 mL/(kg*min); p < 0.0005) without differences between time points (p = 0.11) or training groups (p = 0.15). Etiology did not influence changes of LVEDD or LVEF (p = 0.30; p = 0.12), even when adjusting for sex, age and smoking status (p = 0.54; p = 0.12). Similar findings were observed after 52 weeks. Conclusions Etiology of HFrEF did not influence the effects of moderate or high intensity exercise on cardiac dimensions, systolic function or exercise capacity.en_US
dc.language.isoengen_US
dc.publisherElsevier Scienceen_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/deed.no*
dc.titleModerate continuous or high intensity interval exercise in heart failure with reduced ejection fraction: Differences between ischemic and non-ischemic etiologyen_US
dc.title.alternativeModerate continuous or high intensity interval exercise in heart failure with reduced ejection fraction: Differences between ischemic and non-ischemic etiologyen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.source.pagenumber6en_US
dc.source.volume22en_US
dc.source.journalAmerican Heart Journal Plus: Cardiology Research and Practice (AHJ Plus)en_US
dc.identifier.doi10.1016/j.ahjo.2022.100202
dc.identifier.cristin2062117
dc.source.articlenumber100202en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Attribution-NonCommercial-NoDerivatives 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Attribution-NonCommercial-NoDerivatives 4.0 Internasjonal